BalamuraliKrishnaAmbatiMD

Anterior Segment Related, Cornea & External Disease, Refractive Surgery

Ophthalmologist at Pacific ClearVision Institute

Dr. Ambati is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
360 S. Garden Way
Ste. 250
Eugene, OR 97401
Phone+1 541-343-5000

Fax+1 541-344-9478

Duke University HospitalFellowship, Cornea, External Diseases, and Refractive Surgery, 2001 - 2002
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 1998 - 2001
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1996 - 1998
New York Presbyterian Hospital (Cornell Campus)Internship, Internal Medicine, 1995 - 1996
Icahn School of Medicine at Mount SinaiClass of 1995

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Science Signaling Breakthrough of the Year Science STKE
Physician-Scientist Award Research to Prevent Blindness
Utah Health Care Hero Utah Business Magazine
Genentech Award for Research in Macular Degeneration ARVO
Troutman-Veronneau Prize for Cornea Pan-American Association of Ophthalmology
Arnold Gold Humanism Award University of Utah School of Medicine Students Association
Join now to see all

PubMed

48 citations
Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization.
Yureeda Qazi, Brian C. Stagg, Nirbhai Singh, S. Singh, Xiaohui Zhang
Investigative Ophthalmology & Visual Science. 2012-05-14
75 citations
Periorbital and orbital cellulitis before and after the advent of Haemophilus influenzae type B vaccination.
Balamurali K. Ambati, Jayakrishna Ambati, Nathalie F. Azar, Larry Stratton, Emmett V. Schmidt
Ophthalmology. 2000-08-01
697 citations
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Mark E. Kleinman, Kiyoshi Yamada, Atsunobu Takeda, Vasu Chandrasekaran, Miho Nozaki
Nature. 2008-04-03

Journal Articles

Hydrogel Ocular Sealant for Wound Closure During Intrastromal Corneal Ring Segment Implantation
Balamurali Ambati, MD, Journal of Cataract & Refractive Surgery
Hydrogel Ocular Sealant for Wound Closure During Intrastromal Corneal Ring Segment Implantation
Balamurali Ambati, MD, Journal of Cataract & Refractive Surgery

$Standardizing Terms in Cataract and Refractive Surgery$
Standardizing Terms in Cataract and Refractive SurgeryMarch 24th, 2023
Start Codon Disruption with CRISPR-Cas9 Gene Editing Prevents Fuchs’ Corneal Dystrophy in MiceAugust 3rd, 2021
Safety, Tolerability, and Efficacy of Aflibercept in Patients with Neovascular Age-Related Macular Degeneration (CANDELA)October 15th, 2019
Join now to see all

Intraceptor Interference of VEGF in Corneal & Retinal AngiogenesisNational Eye Institute2014–Present
Morpholino Interference of VEGF in Ocular AngiogenesiDept. of Veterans Affairs2013–Present
The Role of sFlt & Raver in Ocular Vascular DemarcationNational Eye Institute2013–Present
Pre-Mrna Interference Of VEGF Pathways In Ocular AngiogenesisVeterans Affairs2011–2012
The Role Of Sflt In Corneal AvascularityNational Eye Institute2008–2012
Intraceptor Interference Of VEGF PathwaysNational Eye Institute2008–2011
Sulfated Polysaccharide Derivatives For Treatment Of Macular DegenerationNational Eye Institute2009
Intraceptor Interference Of VEGF PathwaysNational Eye Institute2007